FINWIRES · TerminalLIVE
FINWIRES

Keefe Bruyette & Woods Upgrades Core Scientific to Outperform From Market Perform, Adjusts PT to $28 From $25

By

Core Scientific (CORZ) has an average rating of buy and mean price target of $36, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles

Research

Northland Securities Initiates Coverage on NeoVolta With Outperform Rating, $15 Price Target

Northland Securities Initiates Coverage on NeoVolta With Outperform Rating, $15 Price Target

$NEOV
Research

BofA Securities Upgrades Humana to Buy From Neutral, Raises Price Target to $500 From $410

Humana (HUM) has an average rating of hold and mean price target of $350.54, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $365.15, Change: $-23.56, Percent Change: -6.06%

$HUM
Research

Oppenheimer Initiates Quince Therapeutics at Outperform With $82 Price Target

$QNCX